Remove 2021 Remove Pharmacokinetics Remove Therapies
article thumbnail

Contezolid

New Drug Approvals

3] In 2021, it was approved by the National Medical Products Administration of China for the treatment of complicated skin and soft tissue infections (cSSTI). [3] 3] In 2021, it was approved by the National Medical Products Administration of China for the treatment of complicated skin and soft tissue infections (cSSTI). [3]

article thumbnail

A spatial approach to understanding drug dynamics using mass spectrometry imaging

Drug Target Review

Unlike traditional pharmacokinetic (PK) studies that rely on plasma measurements alone, MSI, when combined with traditional histology, enables spatial mapping of drug distribution, metabolism and target engagement. 2021, 56 (8), e4717. 2021, 32 (4), 977–988. Mass Spectrom. Xie F, Gales T, Ringenberg MA, et al. Mass Spectrom.

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Time for change: non-human primates in drug research

Drug Target Review

Their unique suitability has made them valuable for evaluating pharmacokinetics, toxicology and safety in drug candidates before human clinical trials. Since 2021, institutions like the National Primate Research Centers (NPRCs) have reported their inability to meet up to two-thirds of requests for research monkeys.

article thumbnail

Crinecerfont

New Drug Approvals

2] The US Food and Drug Administration (FDA) granted the application for crinecerfont fast track , breakthrough therapy , orphan drug , and priority review designations. [2] New Drug Therapy Approvals 2024 (PDF). 2021 Nov 30;186(1):R1-R14. 2] The FDA granted the approval of Crenessity to Neurocrine Biosciences, Inc. [2]

FDA 62
article thumbnail

Landiolol

New Drug Approvals

Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias” Clinical Pharmacology and Therapeutics. 28 October 2021. New Drug Therapy Approvals 2024 (PDF). February 2021). 32 (2): 828. doi : 10.1016/j.joa.2015.09.002. 2015.09.002. PMC 4823575.

FDA 62
article thumbnail

Best-in-Class Solutions Accelerate Development of GLP-1 Therapeutics

PPD

This expansion is creating opportunities for clinical trials related to a range of new therapy areas and their subpopulations. It is worth noting that trial ran from 2018 to 2021, before the U.S. For example, the SELECT trial enrollment comprised just 28% of women participants and 12% Black participants.

article thumbnail

AZVUDINE

New Drug Approvals

SYN [link] Azvudine was approved for the treatment of adult HIV-1 infection in China in 2021, and it was approved for conditional marketing for the treatment of SARS-CoV-2 in China in 2022. It was approved in China in 2021 as a first-in-class treatment for human immunodeficiency virus (HIV). 2021, 6, 414. (9) Signal Transduct.

RNA 62